Nplate is a Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Romiplostim.
Product ID | 55513-221_0065c77d-0a8e-48d8-8f1f-fc78f6cacc41 |
NDC | 55513-221 |
Product Type | Human Prescription Drug |
Proprietary Name | Nplate |
Generic Name | Romiplostim |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2008-08-25 |
Marketing Category | BLA / BLA |
Application Number | BLA125268 |
Labeler Name | Amgen Inc |
Substance Name | ROMIPLOSTIM |
Active Ingredient Strength | 250 ug/.5mL |
Pharm Classes | Increased Megakaryocyte Maturation [PE],Increased Platelet Production [PE],Thrombopoietin Receptor Agonist [EPC],Thrombopoietin Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2008-08-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125268 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2008-08-25 |
Ingredient | Strength |
---|---|
ROMIPLOSTIM | 250 ug/.5mL |
SPL SET ID: | c45f9a58-37c1-4f76-8e36-97d38c577037 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
55513-221 | Nplate | romiplostim |
55513-222 | Nplate | romiplostim |
55513-223 | Nplate | romiplostim |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NPLATE 78732010 3574008 Live/Registered |
Amgen Inc. 2005-10-12 |